Kolon Life Science Inc. (KOSDAQ: 102940)
South Korea
· Delayed Price · Currency is KRW
23,700
0.00 (0.00%)
Jan 17, 2025, 9:00 AM KST
Kolon Life Science Revenue
Kolon Life Science had revenue of 35.92B KRW in the quarter ending September 30, 2024, with 27.31% growth. This brings the company's revenue in the last twelve months to 147.98B, up 13.52% year-over-year. In the year 2023, Kolon Life Science had annual revenue of 124.64B, down -22.86%.
Revenue (ttm)
147.98B
Revenue Growth
+13.52%
P/S Ratio
1.77
Revenue / Employee
352.33M
Employees
420
Market Cap
278.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 124.64B | -36.94B | -22.86% |
Dec 31, 2022 | 161.58B | -3.90B | -2.36% |
Dec 31, 2021 | 165.49B | 36.07B | 27.87% |
Dec 31, 2020 | 129.41B | -19.13B | -12.88% |
Dec 31, 2019 | 148.54B | 7.29B | 5.16% |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |